Haisco grants license to Sentivera; ViiV's HIV treatment OK'd for newborns

Haisco Pharmaceutical licenses inflammatory disease drug to Sentivera: The Chinese biotech is granting ex-China rights for the unnamed candidate to US startup Sentivera, which was founded by ARCH Venture Partners and Population ...